AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 95 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,724,364 | +843.7% | 740,496 | +1540.4% | 0.00% | – |
| Q2 2023 | $500,603 | +2906.3% | 45,140 | -94.0% | 0.00% | -100.0% |
| Q4 2022 | $16,652 | -97.4% | 750,445 | +1828.5% | 0.01% | – |
| Q3 2022 | $635,000 | +40.2% | 38,913 | +104.2% | 0.00% | – |
| Q4 2021 | $453,000 | +19.8% | 19,053 | +24.0% | 0.00% | – |
| Q3 2021 | $378,000 | +89.0% | 15,360 | +89.6% | 0.00% | – |
| Q2 2021 | $200,000 | -90.1% | 8,100 | -91.3% | 0.00% | -100.0% |
| Q1 2021 | $2,030,000 | -23.7% | 93,096 | -10.7% | 0.00% | -50.0% |
| Q4 2020 | $2,660,000 | -58.4% | 104,216 | -53.9% | 0.00% | -77.8% |
| Q2 2020 | $6,388,000 | – | 226,044 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
| COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
| Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
| 5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
| RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
| RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
| COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
| Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
| Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
| Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |